The function of miRNA in cardiac hypertrophy

Cellular and Molecular Life Sciences

Volumn 69, Issue 21, 2012, Pages 3561-3570

  Wang, Jian ^a   Yang, Xiao ^a,b  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cardiac hypertrophy; miRNAs; Signaling pathway; Therapeutic target

Indexed keywords

ANTAGOMIR 199B; ANTAGOMIR 23A; ANTAGOMIR 27B; ANTISENSE OLIGONUCLEOTIDE; CALCINEURIN; CARDIOVASCULAR AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 133; MICRORNA 146; MICRORNA 208A; MICRORNA 21; MICRORNA 23A; MICRORNA 29; MICRORNA 30; MICRORNA 98; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; THYROID HORMONE; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

DRUG MECHANISM; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; GENE SILENCING; GENE TARGETING; GENETIC REGULATION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HIGH THROUGHPUT SEQUENCING; HORMONAL REGULATION; HUMAN; MICROARRAY ANALYSIS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CARDIOMEGALY; DISEASE MODELS, ANIMAL; HEART FAILURE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICRORNAS; NF-KAPPA B; SIGNAL TRANSDUCTION; THYROID HORMONES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84867849133     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1126-y     Document Type: Review

References (58)

1. Olson EN (2006) Gene regulatory networks in the evolution and development of the heart. Science 313:1922-1927
2. Iismaa SE, Graham RM (2003) Dissecting cardiac hypertrophy and signaling pathways. Circ Res 92:1059-1061
3. Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45-79
4. da Costa Martins PA, Bourajjaj M, Gladka M, Kortland M, van Oort RJ, Pinto YM, Molkentin JD, De Windt LJ (2008) Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 118:1567- 1576
5. Thum T, Catalucci D, Bauersachs J (2008) MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res 79:562-570
6. Carrington JC, Ambros V (2003) Role of microRNAs in plant and animal development. Science 301:336
7. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146:353-358
8. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103:18255- 18260
9. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100:416-424
10. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, Gross C, Engelhardt S, Ertl G, Bauersachs J (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116:258-267
11. Naga Prasad SV, Duan Z, Gupta MK, Surampudi VSK, Volinia S, Calin GA, Liu C, Kotwal A, Moravec CS, Starling RC, Perez DM, Sen S, Wu Q, Plow EF, Croce CM, Karnik S (2009) MicroRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 284:27487-27499
12. Kahaly GJ, Dillmann WH (2005) Thyroid hormone action in the heart. Endocr Rev 26:704-728
13. Dillmann W (2010) Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev 15:125-132
14. Callis TE, Pandya K, Seok HY, Tang R, Tatsuguchi M, Huang Z, Chen J, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang DZ (2009) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119:2772- 2786
15. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ Jr, Olson EN (2009) A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17:662-673
16. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316:575-579
17. Shieh JTC, Huang Y, Gilmore J, Srivastava D (2011) Elevated miR-499 levels blunt the cardiac stress response. PLoS One 6:e19481
18. Ellison GM, Waring CD, Vicinanza C, Torella D (2012) Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms. Heart 98:5-10
19. Walsh K (2006) Akt signaling and growth of the heart. Circulation 113:2032-2034
20. Catalucci D, Latronico MVG, Condorelli G (2008) MicroRNAs control gene expression. Ann N Y Acad Sci 1123:20-29
21. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MVG, Høydal M, Autore C, Russo MA, Dorn GW II, Ellingsen Ø, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613-618
22. Elia L, Contu R, Quintavalle M, Varrone F, Chimenti C, Russo MA, Cimino V, De Marinis L, Frustaci A, Catalucci D, Condorelli G (2009) Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 120:2377-2385
23. Hua Y, Zhang Y, Ren J (2012) IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a. J Cell Mol Med 16:83-95
24. Schultz Jel J, Witt SA, Glascock BJ, Nieman ML, Reiser PJ, Nix SL, Kimball TR, Doetschman T (2002) TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 109:787-796
25. Rosenkranz S, Flesch M, Amann K, Haeuseler C, Kilter H, Seeland U, Schlüter KD, Böhm M (2002) Alterations of b-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-b1. Am J Physiol Heart Circ Physiol 283:H1253-H1262
26. Wang J, Xu N, Feng X, Hou N, Zhang J, Cheng X, Chen Y, Zhang Y, Yang X (2005) Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ Res 97:821-828
27. Divakaran V, Adrogue J, Ishiyama M, Entman ML, Haudek S, Sivasubramanian N, Mann DL (2009) Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading. Circ Heart Fail 2:633-642
28. Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD (2006) GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 98:342-350
29. Chen H, Yong W, Ren S, Shen W, He Y, Cox KA, Zhu W, Li W, Soonpaa M, Payne RM, Franco D, Field LJ, Rosen V, Wang Y, Shou W (2006) Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth. J Biol Chem 281:27481-27491
30. Wang J, Song Y, Zhang Y, Xiao H, Sun Q, Hou N, Guo S, Wang Y, Fan K, Zhan D, Zha L, Cao Y, Li Z, Cheng X, Zhang Y, Yang X (2012) Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res 22: 516-527
31. Sun Q, Zhang Y, Yang G, Chen X, Zhang Y, Cao G, Wang J, Sun Y, Zhang P, Fan M, Shao N, Yang X (2008) Transforming growth factor-b-regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res 36:2690-2699
32. Lin Z, Murtaza I, Wang K, Jiao J, Gao J, Li P (2009) miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci USA 106:12103-12108
33. Dong DL, Chen C, Huo R, Wang N, Li Z, Tu YJ, Hu JT, Chu X, Huang W, Yang BF (2010) Reciprocal repression between MicroRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension 55:946-952
34. da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, van der Nagel R, van Kuik J, de Weger R, de Bruin A, Condorelli G, Arbones ML, Eschenhagen T, De Windt LJ (2010) MicroRNA- 199b targets the nuclear kinase Dyrk1a in an autoamplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 12:1220-1227
35. Kuhn C, Frank D, Will R, Jaschinski C, Frauen R, Katus HA, Frey N (2009) DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy. J Biol Chem 284:17320-17327
36. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, Shindo T, Sano M, Otsu K, Snider P, Conway SJ, Nagai R (2010) Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 120:254-265
37. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, Chun B, Zhuang J, Zhang C (2010) Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 87:431-439
38. van Rooij E, Marshall WS, Olson EN (2008) Toward MicroRNAbased therapeutics for heart disease: the sense in antisense. Circ Res 103:919-928
39. Davis BN, Hilyard AC, Lagna G, Hata A (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454:56-61
40. Zavadil J, Narasimhan M, Blumenberg M, Schneider RJ (2007) Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 185:157-161
41. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, Engelhardt S (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980-984
42. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp med 207:1589-1597
43. Zhong X, Chung ACK, Chen HY, Meng XM, Lan HY (2011) Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22:1668-1681
44. Patrick DM, Montgomery RL, Qi X, Obad S, Kauppinen S, Hill JA, van Rooij E, Olson EN (2010) Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 120:3912-3916
45. Roy S, Khanna S, Hussain SRA, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ, Sen CK (2009) MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 82:21-29
46. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105:13027-13032
47. Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH (2000) CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 32:1805-1819
48. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, Maessen JG, Heymans S, Pinto YM, Creemers EE (2009) miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of MicroRNAs in myocardial matrix remodeling. Circ Res 104:170-178
49. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN (2008) microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 22:3242-3254
50. Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, Dorn LE, Condorelli G, Diwan A, Nerbonne JM, Dorn GW II (2010) MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 106:166-175
51. Devaux B, Scholz D, Hirche A, Klovekorn WP, Schaper J (1997) Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J 18:470-479
52. Frantz S, Fraccarollo D, Wagner H, Behr TM, Jung P, Angermann CE, Ertl G, Bauersachs J (2003) Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. Cardiovasc Res 57:749-756
53. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T (1997) In vivo transfection of cis element ''decoy'' against nuclear factor- kappaB binding site prevents myocardial infarction. Nat Med 3:894-899
54. Taganov KD, Boldin MP, Chang KJ, Baltimore D (2006) NF-jBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103:12481-12486
55. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C (2007) MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 170:1831-1840
56. Yang Y, Ago T, Zhai P, Abdellatif M, Sadoshima J (2011) Thioredoxin 1 negatively regulates angiotensin ii-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circ Res 108:305-313
57. Montgomery RL, Hullinger TG, Semus HM, Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN, van Rooij E (2011) Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124:1537-1547
58. Thum T, Chau N, Bhat B, Gupta SK, Linsley PS, Bauersachs J, Engelhardt S (2011) Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. J Clin Invest 121:461-462